Activated FGFR2 signalling as a biomarker for selection of intrahepatic cholangiocarcinoma patients candidate to FGFR targeted therapies

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
1 Online-Ressource.
Language
Englisch

Bibliographic citation
Activated FGFR2 signalling as a biomarker for selection of intrahepatic cholangiocarcinoma patients candidate to FGFR targeted therapies ; volume:14 ; number:1 ; day:7 ; month:2 ; year:2024 ; pages:1-13 ; date:12.2024
Scientific reports ; 14, Heft 1 (7.2.2024), 1-13, 12.2024

Creator
Brandi, Giovanni
Relli, Valeria
Deserti, Marzia
Palloni, Andrea
Indio, Valentina
Astolfi, Annalisa
Serravalle, Salvatore
Mattiaccio, Alessandro
Vasuri, Francesco
Malvi, Deborah
Deiana, Chiara
Pantaleo, Maria Abbondanza
Cescon, Matteo
Rizzo, Alessandro
Katoh, Masaru
Tavolari, Simona
Contributor
SpringerLink (Online service)

DOI
10.1038/s41598-024-52991-8
URN
urn:nbn:de:101:1-2404160818230.721264806980
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:57 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Brandi, Giovanni
  • Relli, Valeria
  • Deserti, Marzia
  • Palloni, Andrea
  • Indio, Valentina
  • Astolfi, Annalisa
  • Serravalle, Salvatore
  • Mattiaccio, Alessandro
  • Vasuri, Francesco
  • Malvi, Deborah
  • Deiana, Chiara
  • Pantaleo, Maria Abbondanza
  • Cescon, Matteo
  • Rizzo, Alessandro
  • Katoh, Masaru
  • Tavolari, Simona
  • SpringerLink (Online service)

Other Objects (12)

Transarterial Therapies for the Treatment of Intrahepatic Cholangiocarcinoma

Transarterial Therapies for the Treatment of Intrahepatic Cholangiocarcinoma

Dual FGFR and VEGFR inhibition synergistically restrain hexokinase 2-dependent lymphangiogenesis and immune escape in intrahepatic cholangiocarcinoma

Dual FGFR and VEGFR inhibition synergistically restrain hexokinase 2-dependent lymphangiogenesis and immune escape in intrahepatic cholangiocarcinoma

Leveraging patient derived models of FGFR2 fusion positive intrahepatic cholangiocarcinoma to identify synergistic therapies

Leveraging patient derived models of FGFR2 fusion positive intrahepatic cholangiocarcinoma to identify synergistic therapies

Characterization of the cholangiocarcinoma drug pemigatinib against FGFR gatekeeper mutants

Characterization of the cholangiocarcinoma drug pemigatinib against FGFR gatekeeper mutants

A murine model of FGFR2 fusion driven intrahepatic cholangiocarcinoma to delineate the mechanism of therapeutic response and resistance to FGFR inhibitors

A murine model of FGFR2 fusion driven intrahepatic cholangiocarcinoma to delineate the mechanism of therapeutic response and resistance to FGFR inhibitors

MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma

MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma

Benchmarks in Liver Resection for Intrahepatic Cholangiocarcinoma

Benchmarks in Liver Resection for Intrahepatic Cholangiocarcinoma

The focus clinical research in intrahepatic cholangiocarcinoma

The focus clinical research in intrahepatic cholangiocarcinoma

Differential enrichment of H3K9me3 in intrahepatic cholangiocarcinoma

Differential enrichment of H3K9me3 in intrahepatic cholangiocarcinoma

Prognostic factors in patients with intrahepatic cholangiocarcinoma

Prognostic factors in patients with intrahepatic cholangiocarcinoma

Precision oncology for intrahepatic cholangiocarcinoma in clinical practice

Precision oncology for intrahepatic cholangiocarcinoma in clinical practice

Intrahepatic cholangiocarcinoma hidden within cancer of unknown primary

Intrahepatic cholangiocarcinoma hidden within cancer of unknown primary

Related objects